Föreläsningar och seminarier CCK lecture: Challenges and strategies for the development of EBV vaccine

Speaker: Musheng Zeng, Professor, Vice President, Director of Research, SunYat Sen Cancer Center, Guangzhou, China

There is a growing interest in developing a vaccine to EBV, due to the cancer risk and to the emerging strong link of EBV-infection to the pathogenesis of multiple sclerosis (MS). Professor Musheng Zeng is one of the worlds leading scientists in the studies of EBV.

Host: CCK together with KI-China faculty

Contacts at Karolinska Institutet
Ingemar Ernberg, Maria Masucci